CoronaryAtlas logo
CoronaryAtlas
P-selectin (CD62P)
Pathway / Platelet adhesion & activation

P-selectin (CD62P)

protein

P-selectin (CD62P) mediates platelet–leukocyte adhesion and tethering, amplifying thromboinflammation in Type 1 MI.

Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencehigh
RationaleP-selectin anchors platelet adhesion and leukocyte recruitment; marker of platelet activation.
Also acts inVascular inflammation, Endothelial activation/erosion
Druggability
Not assessed (no mapped human gene target).

Type I vs non-Type I discrimination

ScoresNon-Type-I-associated
R — rupture / Type-I
C — non-Type-I
58
A — assay feasibility
68
E — evidence strength
86
T1DI (composite)
17
Specificity differential (R−C)-43.3
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
2hypovolemia / dehydrationn/a
2tachyarrhythmiamag 2
2hypoxemia / respiratory failuremag 2
2hypertensive emergencymag 3
2high-demand / peri-operative stressmag 2
3sudden cardiac deathn/a
4aPCI-related periproceduralmag 1
4bstent thrombosismag 2
4cin-stent restenosisn/a
5CABG-relatedmag 0
Coverage: 8/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 19 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(2)